Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 60, n. 6, p. 831, doi. 10.1007/s00280-007-0430-y
- By:
- Publication type:
- Article
Works matching AU Awasthi, Anshumali
Results: 6
1
2
Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding.
- Published in:
- Journal of Enzyme Inhibition & Medicinal Chemistry, 2014, v. 29, n. 5, p. 710, doi. 10.3109/14756366.2013.845817
- By:
- Publication type:
- Article
3
Oral Bioavailability Enhancement of Exemestane from Self-Microemulsifying Drug Delivery System (SMEDDS).
- Published in:
- AAPS PharmSciTech, 2009, v. 10, n. 3, p. 906, doi. 10.1208/s12249-009-9281-7
- By:
- Publication type:
- Article
4
Non-toxic melanoma therapy by a novel tubulin-binding agent.
- Published in:
- International Journal of Cancer, 2010, v. 126, n. 1, p. 256, doi. 10.1002/ijc.24765
- By:
- Publication type:
- Article
5
Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel.
- Published in:
- Clinical & Translational Oncology, 2013, v. 15, n. 1, p. 26, doi. 10.1007/s12094-012-0883-2
- By:
- Publication type:
- Article
6
Application of a liquid chromatography-electrospray mass spectrometry (LC/MS) method to the biodistribution and excretion studies of novel 5′-chloro-2, 3-didehydroindolo (2′, 3′: 2, 3) betulinic acid (DRF-4012) in tumour-bearing mice.
- Published in:
- Xenobiotica, 2013, v. 43, n. 6, p. 548, doi. 10.3109/00498254.2012.747709
- By:
- Publication type:
- Article